Antiplatelet Therapy and Cardiovascular Diseases

Работ: 37

1. Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures

   E. Shalaeva, Hugo Saner, B. Janabaev +1

   СтатьяAntiplatelet Therapy and Cardiovascular DiseasesEuropean Journal of Preventive Cardiology2017Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.134863

2. Polyelectrolyte Microcapsules—A Promising Target Delivery System of Amiodarone with the Possibility of Prolonged Release

   Aleksandr L. Kim, Egor V. Musin, M. Zh. Oripova +3

   СтатьяAtrial Fibrillation Management and OutcomesInternational Journal of Molecular Sciences2023Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.317658

3. QANDLI DIABET KASALLIGI FONIDA YURAK QON TOMIR TIZIMI KASALLIKLARINING KLINIK KECHUV XUSUSIYATLARI

   Исламова Камола Акрамовна, Карабаева Гульчехра Худойбердиевна

   СтатьяDiabetes, Cardiovascular Risks, and Lipoproteins2020Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.721580

4. Resveratrol Inhibits Platelet Aggregation in Aspirin Resistance

   Gyorgyi Stef, Kenneth M. Lerea, Joseph Wu +2

   СтатьяAntiplatelet Therapy and Cardiovascular DiseasesThe FASEB Journal2006Цитирований: 0

   ABIABI:AkademIndex/openalex/2006.article.000452

5. Polysthicol

   Shakhnoza S. Azimova

   ГлаваCase Reports on Hematomas2012Цитирований: 0

   ABIABI:AkademIndex/openalex/2012.chapter.001929

6. Methylquadrangularate C

   Shakhnoza S. Azimova

   ГлаваCancer Treatment and Pharmacology2012Цитирований: 0

   ABIABI:AkademIndex/openalex/2012.chapter.005073

7. Influence of Lipid Transport System Gene Polymorphism on the Dyslipidemia and Coronary Lesions in Patients with Unstable Angina

   A. S. Eshpulatov, Tashkent, Uzbekistan, Shavkat Hashimov +2

   СтатьяLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine2015Цитирований: 0

   ABIABI:AkademIndex/openalex/2015.article.000792

8. One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent

   Nabijon Yuldashev, Robert Gil, R. D. Kurbanov

   СтатьяCoronary Interventions and DiagnosticsInternational Journal of Biomedicine2018Цитирований: 0

   ABIABI:AkademIndex/openalex/2018.article.000491

9. PO149 Compliance of Patients With Coronary Artery Disease In Correlation With Clinical and Angiographic Data

   G. Nagaeva, N. Juldashev, S. Nagaev

   СтатьяPeripheral Artery Disease ManagementGlobal Heart2018Цитирований: 0

   ABIABI:AkademIndex/openalex/2018.article.000880

10. Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms

    Jamol Uzokov, B. A. Alyavi

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.article.001189

11. Prevalence and Features of Aspirin Resistance in Patients with Coronary Artery Disease

    Khodjanova SH

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesCross Current International Journal of Medical and Biosciences2020Цитирований: 0

    ABIABI:AkademIndex/openalex/2020.article.005217

12. Evaluations of Hemostatic Activity of Ethanol Extract of Euonymus fortunei Aerial Parts

    Xi‐Lin Ouyang, Lin-Yan Shu, Xiaoya Qin +1

    СтатьяPlatelet Disorders and TreatmentsJournal of Pharmaceutical Research International2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.000911

13. Aspirin Resistance in Patients with Chronic Coronary Syndrome

    A. L. Alyavi, Sh.I.Khodjanova, Jamol Uzokov +1

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesIndian Journal of Forensic Medicine & Toxicology2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.002392

14. Antiplatelet therapy with clopidogrel taking into account CYP2C19 genetic polymorphisms in patients with coronary heart disease after coronary artery stenting

    Jamol Uzokov, B. A. Alyavi, A. Abdullaev +2

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.008297

15. ANTIPLATELET THERAPY AND SECONDARY PROPHYLAXIS AFTER CORONARY BYPASS SURGERY IN ACUTE CORONARY SYNDROME

    Jalilov A.K., Isadora Almeida G

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesMedical & pharmaceutical journal Pulse2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.008457

16. The value of the Left Ventricular Emission Fraction in Patients with Ischaemic Heart Disease with Diabetes Mellitus 2 in the Assessment of the Effectiveness of Sitagliptin/Metformin

    Раиса Тригулова, Dilnoza Alimova, N.F. Tashkenbaeva +4

    СтатьяDiabetes Treatment and ManagementAmerican Heart Journal2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.009215

17. YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA ATSETILSALITSIL KISLOTANING ANTIAGREGANT VA YALLIG'LANISHGA QARSHI XUSUSIYATLARI

    Шахноза Искандаровна Ходжанова

    СтатьяAntiplatelet Therapy and Cardiovascular Diseases2021Цитирований: 0

    ABIABI:AkademIndex/openalex/2021.article.013019

18. Advantages of aspirin in the prevention of cardiovascular disease

    M Niladri, Gayatri Devi, Prateek Porwal +4

    СтатьяInflammatory mediators and NSAID effectsInternational Journal of Health Sciences2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.005434

19. Polymorphism in the apolipoprotein C3 gene and coronary lesions in patients with CHD

    Р Алиева, A. Eshpulatov, Aleksandr B. Shek

    СтатьяLipoproteins and Cardiovascular HealthAtherosclerosis2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.007489

20. Clopidogrel efficacy after percutaneous coronary interventions considering with CYP2C19 genetic polymorphisms in patients with coronary heart disease

    Jamol Uzokov, B. Alyavi, A. Kh. Abdullaev +2

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.007497

21. #4878 STUDYING THE EFFECTIVENESS OF PRASUGREL AND CLOPIDOGEL IN PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA WITH STAGE 2 CKD

    Yorkin Rasulev, Durdona Adylova

    СтатьяPeripheral Artery Disease ManagementNephrology Dialysis Transplantation2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.001882

22. Ticagrelor in the treatment of patients with acute coronary syndrome: own clinical experience

    Н Юлдошев, Г. А. Нагаева, М. Ж. Журалиев +3

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesThe Bulletin of Emergency Medicine2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.003207

23. Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions

    M Mukhamedova, D Z Orziev, Jamol Uzokov +1

    СтатьяAntiplatelet Therapy and Cardiovascular DiseasesEuropean Journal of Cardiovascular Nursing2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.003884

24. Relationship between blood inflammation state and platelet aggregation rate in patients with atherosclerotic coronary artery disease after percutaneous coronary interventions

    Jamol Uzokov, Bakhromkhon Alyavi, B. Karimov +1

    СтатьяInflammatory Biomarkers in Disease PrognosisAtherosclerosis2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.003955

25. CHANGES IN THE LEVEL OF C-REACTIVE PROTEIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WHILE TAKING COLCHICINE

    Agababyan Irina Rubenovna, KOBILOVA Nigina Akmalovna

    СтатьяLipoproteins and Cardiovascular HealthZenodo (CERN European Organization for Nuclear Research)2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.009920